Skip to Content
Merck
  • Adipose mesenchymal stem cells combined with platelet-rich plasma accelerate diabetic wound healing by modulating the Notch pathway.

Adipose mesenchymal stem cells combined with platelet-rich plasma accelerate diabetic wound healing by modulating the Notch pathway.

Stem cell research & therapy (2021-07-15)
Nesrine Ebrahim, Arigue A Dessouky, Ola Mostafa, Amira Hassouna, Mohamed M Yousef, Yasmin Seleem, Eman Abd El Aziz M El Gebaly, Mona M Allam, Ayman Samir Farid, Bayan A Saffaf, Dina Sabry, Ahmed Nawar, Ahmed A Shoulah, Ahmed H Khalil, Sami F Abdalla, Mohamed El-Sherbiny, Nehal M Elsherbiny, Rabab F Salim
ABSTRACT

Diabetic foot ulceration is a serious chronic complication of diabetes mellitus characterized by high disability, mortality, and morbidity. Platelet-rich plasma (PRP) has been widely used for diabetic wound healing due to its high content of growth factors. However, its application is limited due to the rapid degradation of growth factors. The present study aimed to evaluate the efficacy of combined adipose-derived mesenchymal stem cells (ADSCs) and PRP therapy in promoting diabetic wound healing in relation to the Notch signaling pathway. Albino rats were allocated into 6 groups [control (unwounded), sham (wounded but non-diabetic), diabetic, PRP-treated, ADSC-treated, and PRP+ADSCs-treated groups]. The effect of individual and combined therapy was evaluated by assessing wound closure rate, epidermal thickness, dermal collagen, and angiogenesis. Moreover, gene and protein expression of key elements of the Notch signaling pathway (Notch1, Delta-like canonical Notch ligand 4 (DLL4), Hairy Enhancer of Split-1 (Hes1), Hey1, Jagged-1), gene expression of angiogenic marker (vascular endothelial growth factor and stromal cell-derived factor 1) and epidermal stem cells (EPSCs) related gene (ß1 Integrin) were assessed. Our data showed better wound healing of PRP+ADSCs compared to their individual use after 7 and 14 days as the combined therapy caused reepithelialization and granulation tissue formation with a marked increase in area percentage of collagen, epidermal thickness, and angiogenesis. Moreover, Notch signaling was significantly downregulated, and EPSC proliferation and recruitment were enhanced compared to other treated groups and diabetic groups. These data demonstrated that PRP and ADSCs combined therapy significantly accelerated healing of diabetic wounds induced experimentally in rats via modulating the Notch pathway, promoting angiogenesis and EPSC proliferation.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Oct-4 Antibody, Chemicon®, from rabbit
Sigma-Aldrich
Anti-PCNA antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
ANTI-CD105 (CENTER E395) antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-CD31 antibody, Rabbit monoclonal, clone SP164, recombinant, expressed in proprietary host, affinity isolated antibody